NCT01846117View on ClinicalTrials.gov

Once-Daily Oral Dose of BeneFlax to Healthy Older Adults

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions
Oxidative StressInflammationAgingPain
Interventions
DIETARY_SUPPLEMENT

secoisolariciresinol diglucoside, vitamin D

SDG supplementation as a packet of 1.6g/day of BeneFlax containing 600 mg SDG for 24 weeks Vitamin D Natural Product Number (NPN) 80003663 WN Pharmaceuticals Natural Factors Whey Factors

Trial Locations (1)

S7K 0M7

Saskatoon Centre for Patient-Oriented Research, Saskatoon

All Listed Sponsors
collaborator

Saskatchewan Health Research Foundation

OTHER

lead

University of Saskatchewan

OTHER

NCT01846117 - Once-Daily Oral Dose of BeneFlax to Healthy Older Adults | Biotech Hunter | Biotech Hunter